ginsenoside rh2 has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Kong, W; Li, Z; Liu, W; Wang, L; Wang, Z; Wu, H; Wu, J; Yu, B; Yu, X; Zhang, H | 1 |
| Wang, X; Wang, Y | 1 |
2 other study(ies) available for ginsenoside rh2 and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia.
Topics: Adenoviridae; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genetic Vectors; Ginsenosides; Humans; Leukemia, Myeloid, Acute; Mice; Oncolytic Virotherapy; Oncolytic Viruses; TNF-Related Apoptosis-Inducing Ligand; Virus Replication; Xenograft Model Antitumor Assays | 2020 |
Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Ginsenosides; Humans; Leukemia, Myeloid, Acute; Male; Mice; MicroRNAs; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Survival Analysis | 2015 |